Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 2
2014 2
2015 3
2016 1
2017 1
2018 2
2019 3
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy: Scotland's experience.
Hutchinson SJ, Dillon JF, Fox R, McDonald SA, Innes HA, Weir A, McLeod A, Aspinall EJ, Palmateer NE, Taylor A, Munro A, Valerio H, Brown G, Goldberg DJ. Hutchinson SJ, et al. Among authors: innes ha. Int J Drug Policy. 2015 Nov;26(11):1041-9. doi: 10.1016/j.drugpo.2015.05.019. Epub 2015 Jun 6. Int J Drug Policy. 2015. PMID: 26123893 Free article. Review.
Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland.
Innes HA, Hutchinson SJ, Allen S, Bhattacharyya D, Bramley P, Carman B, Delahooke TE, Dillon JF, Goldberg DJ, Kennedy N, Mills PR, Morris J, Morris J, Robertson C, Stanley AJ, Hayes P; Hepatitis C Clinical Database Monitoring Committee. Innes HA, et al. Eur J Gastroenterol Hepatol. 2012 Jun;24(6):646-55. doi: 10.1097/MEG.0b013e32835201a4. Eur J Gastroenterol Hepatol. 2012. PMID: 22433796 Review.
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis.
McDonald SA, Pollock KG, Barclay ST, Goldberg DJ, Bathgate A, Bramley P, Dillon JF, Fraser A, Innes HA, Kennedy N, Morris J, Went A, Hayes PC, Hutchinson SJ. McDonald SA, et al. Among authors: innes ha. J Viral Hepat. 2020 Mar;27(3):270-280. doi: 10.1111/jvh.13232. Epub 2019 Nov 26. J Viral Hepat. 2020. PMID: 31696575
Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis.
Wang H, Swann R, Thomas E, Innes HA, Valerio H, Hayes PC, Allen S, Barclay ST, Wilks D, Fox R, Bhattacharyya D, Kennedy N, Morris J, Fraser A, Stanley AJ, Gunson R, Mclntyre PG, Hunt A, Hutchinson SJ, Mills PR, Dillon JF. Wang H, et al. Among authors: innes ha. J Viral Hepat. 2018 Aug;25(8):930-938. doi: 10.1111/jvh.12897. Epub 2018 Apr 15. J Viral Hepat. 2018. PMID: 29577515 Free article.
Uptake of endoscopic screening for gastroesophageal varices and factors associated with variceal bleeding in patients with chronic hepatitis C infection and compensated cirrhosis, 2005-2016: a national database linkage study.
McDonald SA, Barclay ST, Hutchinson SJ, Stanley AJ, Fraser A, Dillon JF, Innes HA, Peters E, Kennedy N, Bathgate A, Bramley P, Morris J, Goldberg DJ, Hayes PC. McDonald SA, et al. Among authors: innes ha. Aliment Pharmacol Ther. 2019 Aug;50(4):425-434. doi: 10.1111/apt.15320. Epub 2019 Jun 3. Aliment Pharmacol Ther. 2019. PMID: 31157411
Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes.
Innes HA, McDonald SA, Dillon JF, Allen S, Hayes PC, Goldberg D, Mills PR, Barclay ST, Wilks D, Valerio H, Fox R, Bhattacharyya D, Kennedy N, Morris J, Fraser A, Stanley AJ, Bramley P, Hutchinson SJ. Innes HA, et al. Hepatology. 2015 Aug;62(2):355-64. doi: 10.1002/hep.27766. Epub 2015 Mar 25. Hepatology. 2015. PMID: 25716707
15 results